-
-
-
-
-
-
-
Mirum Pharmaceuticals, Inc. (MIRM) Tops Q3 EPS by 20c ; Offers Guidance
-
-
-
-
-
-
-
Mirum Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
-
-
-
-
-
-
-
Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and PFIC Highlighted at EASL Congress
-
-
-
-
-
-
-
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 results; offers guidance
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023
-
-
-
-
-
-
-
Mirum Pharmaceuticals, Inc. (MIRM) Misses Q2 EPS by 122c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

